Stuart Chaussee & Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-23
Closed -$2K – 132
2019
Q4
$2K Hold
23
– – ﹤0.01% 123
2019
Q3
$2K Hold
23
– – ﹤0.01% 121
2019
Q2
$2K Hold
23
– – ﹤0.01% 124
2019
Q1
$2K Hold
23
– – ﹤0.01% 121
2018
Q4
$2K Hold
23
– – ﹤0.01% 107
2018
Q3
$2K Hold
23
– – ﹤0.01% 129
2018
Q2
$2K Hold
23
– – ﹤0.01% 132
2018
Q1
$2K Hold
23
– – 0.01% 100
2017
Q4
$2K Buy
+23
New +$1.53K ﹤0.01% 110

Other funds holding XYL

Stuart Chaussee & Associates's XYL Position: Q1 2020 in Review

Stuart Chaussee & Associates sold out of Xylem (XYL) in Q1 2020, closing a stake of 23 shares — an estimated $2K sold.

Stuart Chaussee & Associates first reported a position in XYL in Q4 2017 and held it in 9 quarters. The position peaked at $2K in Q4 2019. 673 funds tracked by Wall St. Rank hold XYL as of Q1 2020.

  • Stuart Chaussee & Associates reported no remaining Xylem position as of Q1 2020 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 23 Xylem shares in Q1 2020, an estimated $2K.
  • Stuart Chaussee & Associates first reported a position in Xylem in Q4 2017 and held it in 9 quarters.
  • Stuart Chaussee & Associates's Xylem position peaked at $2K in Q4 2019.
  • 673 funds tracked by Wall St. Rank held Xylem as of Q1 2020.

Based on Stuart Chaussee & Associates's 13F filing for Q1 2020, filed 14 May 2020.